Circulating Apolipoprotein L1 is associated with insulin resistance-induced abnormal lipid metabolism

Circulating ApolipoproteinL1 (ApoL1) is a component of pre-β-high-density lipoprotein (HDL), however little is known about the relationship of ApoL1 with cardiometabolic factors. Considering previous studies reporting the correlation of ApoL1 to triglyceride, we have hypothesized that ApoL1 associat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2019-10, Vol.9 (1), p.14869-11, Article 14869
Hauptverfasser: Nishimura, Kenji, Murakami, Taichi, Sakurai, Toshihiro, Miyoshi, Masashi, Kurahashi, Kiyoe, Kishi, Seiji, Tamaki, Masanori, Tominaga, Tatsuya, Yoshida, Sumiko, Nagai, Kojiro, Abe, Hideharu, Hui, Shu-Ping, Kotani, Kazuhiko, Doi, Toshio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Circulating ApolipoproteinL1 (ApoL1) is a component of pre-β-high-density lipoprotein (HDL), however little is known about the relationship of ApoL1 with cardiometabolic factors. Considering previous studies reporting the correlation of ApoL1 to triglyceride, we have hypothesized that ApoL1 associates with insulin-related metabolism. The current study examined their associations in 126 non-diabetic subjects and 36 patients with type 2 diabetes (T2DM). Non-diabetic subjects demonstrated triglyceride (standardized coefficients [s.c.] = 0.204, p  
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-019-51367-7